B 221 - Marathoner's cure for bowel related problems?

A double blind, placebo-controlled and randomized study was conducted at Stockholm Marathon 2011. The aim was to investigate if egg yolk powder B 221 with high levels of Antisecretory factor could decrease the prevalence of diarrhea among runners that had experienced diarrhea at >50% of their marath...

Full description

Bibliographic Details
Main Author: Köhlerstrand, Martin
Format: Second cycle, A1E
Language:Swedish
Inglés
Published: 2016
Subjects:
Online Access:https://stud.epsilon.slu.se/9010/
_version_ 1855571446646964224
author Köhlerstrand, Martin
author_browse Köhlerstrand, Martin
author_facet Köhlerstrand, Martin
author_sort Köhlerstrand, Martin
collection Epsilon Archive for Student Projects
description A double blind, placebo-controlled and randomized study was conducted at Stockholm Marathon 2011. The aim was to investigate if egg yolk powder B 221 with high levels of Antisecretory factor could decrease the prevalence of diarrhea among runners that had experienced diarrhea at >50% of their marathon races. The study did not reach the planned number of 200 study subjects and also encountered problems with dropouts. The number of study subjects was 55 on the day of the marathon. There was no significant difference between placebo and active treatment (p=0.23). The prevalence of diarrhea was 59% (B 221) and 43% (placebo), respectively. The study could not show that a diet supplemented with B 221 had a decreasing effect on the prevalence of diarrhea in the studied population during the day of the marathon race.
format Second cycle, A1E
id RepoSLU9010
institution Swedish University of Agricultural Sciences
language Swedish
Inglés
publishDate 2016
publishDateSort 2016
record_format eprints
spelling RepoSLU90102016-05-10T12:28:26Z https://stud.epsilon.slu.se/9010/ B 221 - Marathoner's cure for bowel related problems? Köhlerstrand, Martin Food science and technology Human medicine, health, and safety A double blind, placebo-controlled and randomized study was conducted at Stockholm Marathon 2011. The aim was to investigate if egg yolk powder B 221 with high levels of Antisecretory factor could decrease the prevalence of diarrhea among runners that had experienced diarrhea at >50% of their marathon races. The study did not reach the planned number of 200 study subjects and also encountered problems with dropouts. The number of study subjects was 55 on the day of the marathon. There was no significant difference between placebo and active treatment (p=0.23). The prevalence of diarrhea was 59% (B 221) and 43% (placebo), respectively. The study could not show that a diet supplemented with B 221 had a decreasing effect on the prevalence of diarrhea in the studied population during the day of the marathon race. 2016-04-29 Second cycle, A1E NonPeerReviewed application/pdf sv https://stud.epsilon.slu.se/9010/14/kohlerstrand_m_160510.pdf Köhlerstrand, Martin, 2016. B 221 - Marathoner's cure for bowel related problems? : double blind, placebo controlled study of egg powder B 221 in reducing disturbances in the gastrointestinal tract during long distance running. Second cycle, A1E. Uppsala: (NL, NJ) > Dept. of Food Science <https://stud.epsilon.slu.se/view/divisions/OID-550.html> urn:nbn:se:slu:epsilon-s-5337 eng
spellingShingle Food science and technology
Human medicine, health, and safety
Köhlerstrand, Martin
B 221 - Marathoner's cure for bowel related problems?
title B 221 - Marathoner's cure for bowel related problems?
title_full B 221 - Marathoner's cure for bowel related problems?
title_fullStr B 221 - Marathoner's cure for bowel related problems?
title_full_unstemmed B 221 - Marathoner's cure for bowel related problems?
title_short B 221 - Marathoner's cure for bowel related problems?
title_sort b 221 - marathoner's cure for bowel related problems?
topic Food science and technology
Human medicine, health, and safety
url https://stud.epsilon.slu.se/9010/
https://stud.epsilon.slu.se/9010/